BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38542291)

  • 21. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Robust Approach for Identification of Cancer Biomarkers and Candidate Drugs.
    Shahjaman M; Rahman MR; Islam SMS; Mollah MNH
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31212673
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.
    Morera DS; Hasanali SL; Belew D; Ghosh S; Klaassen Z; Jordan AR; Wang J; Terris MK; Bollag RJ; Merseburger AS; Stenzl A; Soloway MS; Lokeshwar VB
    J Urol; 2020 Jan; 203(1):62-72. PubMed ID: 31112107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ArrayExpress update - from bulk to single-cell expression data.
    Athar A; Füllgrabe A; George N; Iqbal H; Huerta L; Ali A; Snow C; Fonseca NA; Petryszak R; Papatheodorou I; Sarkans U; Brazma A
    Nucleic Acids Res; 2019 Jan; 47(D1):D711-D715. PubMed ID: 30357387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
    CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.
    Li D; Mullinax JE; Aiken T; Xin H; Wiegand G; Anderson A; Thorgeirsson S; Avital I; Rudloff U
    BMC Cancer; 2018 Jul; 18(1):772. PubMed ID: 30064387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Expression Detection Assay for Cancer Clinical Use.
    Narrandes S; Xu W
    J Cancer; 2018; 9(13):2249-2265. PubMed ID: 30026820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
    Lee H; Kim N; Yoo YJ; Kim H; Jeong E; Choi S; Moon SU; Oh SH; Mills GB; Yoon S; Kim WY
    Oncogene; 2018 Oct; 37(40):5466-5475. PubMed ID: 29895971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.
    Wee P; Wang Z
    Cancers (Basel); 2017 May; 9(5):. PubMed ID: 28513565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
    Amin MB; Greene FL; Edge SB; Compton CC; Gershenwald JE; Brookland RK; Meyer L; Gress DM; Byrd DR; Winchester DP
    CA Cancer J Clin; 2017 Mar; 67(2):93-99. PubMed ID: 28094848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy.
    Deng X; Nakamura Y
    Trends Pharmacol Sci; 2017 Jan; 38(1):15-24. PubMed ID: 27842888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of colorectal cancer.
    Marley AR; Nan H
    Int J Mol Epidemiol Genet; 2016; 7(3):105-114. PubMed ID: 27766137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer.
    Yang J; Li S; Wang B; Wu Y; Chen Z; Lv M; Lin Y; Yang J
    Tumour Biol; 2016 Sep; 37(9):11645-11655. PubMed ID: 27422777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy.
    Vigneri PG; Tirrò E; Pennisi MS; Massimino M; Stella S; Romano C; Manzella L
    Front Oncol; 2015; 5():230. PubMed ID: 26528439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model.
    Du J; Yang M; Chen S; Li D; Chang Z; Dong Z
    Oncogene; 2016 Jun; 35(25):3314-23. PubMed ID: 26455327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer: from prevention to personalized medicine.
    Binefa G; Rodríguez-Moranta F; Teule A; Medina-Hayas M
    World J Gastroenterol; 2014 Jun; 20(22):6786-808. PubMed ID: 24944469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The causes and consequences of genetic heterogeneity in cancer evolution.
    Burrell RA; McGranahan N; Bartek J; Swanton C
    Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium.
    Schurmann C; Heim K; Schillert A; Blankenberg S; Carstensen M; Dörr M; Endlich K; Felix SB; Gieger C; Grallert H; Herder C; Hoffmann W; Homuth G; Illig T; Kruppa J; Meitinger T; Müller C; Nauck M; Peters A; Rettig R; Roden M; Strauch K; Völker U; Völzke H; Wahl S; Wallaschofski H; Wild PS; Zeller T; Teumer A; Prokisch H; Ziegler A
    PLoS One; 2012; 7(12):e50938. PubMed ID: 23236413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NCBI GEO: archive for functional genomics data sets--update.
    Barrett T; Wilhite SE; Ledoux P; Evangelista C; Kim IF; Tomashevsky M; Marshall KA; Phillippy KH; Sherman PM; Holko M; Yefanov A; Lee H; Zhang N; Robertson CL; Serova N; Davis S; Soboleva A
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D991-5. PubMed ID: 23193258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.